Urgent.News

What's breaking now, across thousands of outlets.

AI

Metaview wants to eliminate recruiting grunt work and speed up hiring after raising $60M in funding

Artificial intelligence recruiting software startup Metaview Labs Inc. said today the industry is ready for a “Claude Code moment” after it closed on $60 million in a Series C funding. The round was led by Insight Partners and saw the participation of GV, Seedcamp, Vertex Ventures US, Intrepid Growth Partners, Plural and Garuda Ventures. To […] The post Metaview wants to eliminate recruiting…

Metaview wants to eliminate recruiting grunt work and speed up hiring after raising $60M in funding

Artificial intelligence recruiting software startup Metaview Labs Inc. has raised $60 million in its Series C funding round, marking a significant moment for the industry. The company, founded in 2018 by former Uber and Palantir employees Siadhal Magos and Shahriar Tajbakhsh, now boasts $110 million in total funding. Metaview's AI agents automate various recruitment tasks, from creating job ads to conducting initial interviews.

With over six million interviews conducted, the startup claims to be helping over 7,000 companies reduce their average time-to-hire by more than 75%. The urgency for automation is heightened by the current economic climate, as applications per recruiter have increased by 412%. Metaview's latest addition is fillmore, an autonomous recruiting agent that can research candidates, generate personalized emails, and schedule meetings.

As part of its growth strategy, Metaview is expanding its platform, opening a new office in New York City, and enhancing its 10x Recruiting program to train human recruiters in AI.

Written by urgent.news from SiliconANGLE's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at siliconangle.com →

More in AI

Lunit Plans Five AI Biomarker Abstracts for ESMO

Lunit announced on Oct. 1 that it will participate in the '2026 European Society for Medical Oncology (ESMO 2026)' held in Madrid, Spain, from Oct.

  • Lunit to present five AI biomarker abstracts at ESMO 2026 in Madrid.
  • Study compares Lunit SCOPE s PD-L1 evaluation with pathologist results.
  • Lunit involved in AIforHER project for breast cancer HER2 analysis.

More from Thursday 1 October →